Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.97 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.97 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.56 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | THPO | P40225 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | APEX1 | P27695 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.53 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.53 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| D-Histidine SCHEMBL288043 | 0.98 | CYP3A4 (1.00) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| Histidine SCHEMBL388560 | 0.98 | CYP3A4 (1.00) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| Histidine SCHEMBL137600 | 0.98 | CYP3A4 (1.00) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| Histidine SCHEMBL30852263 | 0.98 | CYP3A4 (1.00) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| Histidine SCHEMBL19974306 | 0.98 | CYP3A4 (1.00) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| Histidine SCHEMBL28071764 | 0.98 | CYP3A4 (1.00) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| Histidine SCHEMBL3260 | 0.98 | CYP3A4 (1.00) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| Histidine SCHEMBL25357958 | 0.97 | CYP3A4 (0.97) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| Histidine SCHEMBL23002334 | 0.97 | CYP3A4 (0.97) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| Histidine SCHEMBL25267810 | 0.97 | CYP3A4 (0.97) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025030248-A1 | CANNABINOID EMULSION | BLACK & BLUE FOODS INC. (CA) | 2025-02-13 | — | — | WO | claimed |
| EP-3716945-A1 | LIQUID DOSAGE FORMS, METHODS OF MAKING AND USE | Canopy Growth Corporation (CA) | 2020-10-07 | — | — | EP | claimed |
| US-12485129-B2 | Water soluble compositions comprising purified cannabinoids | CANOPY GROWTH CORPORATION (CA) | 2025-12-02 | — | — | US | disclosed |
| WO-2025030248-A1 | CANNABINOID EMULSION | BLACK & BLUE FOODS INC. (CA) | 2025-02-13 | — | — | WO | disclosed |
| US-20240189329-A1 | WATER-SOLUBLE CANNABIS CANNABINOID SYSTEMS FOR INFUSING PRODUCTS WITH NANOEMULSIONS HAVING NANOSCALE SIZES | HEXO OPERATIONS INC. (CA) | 2024-06-13 | — | — | US | disclosed |
| WO-2023028708-A1 | WATER-SOLUBLE CANNABINOID COMPOSITIONS, METHODS OF MAKING AND USE | CANOPY GROWTH CORPORATION (CA) | 2023-03-09 | — | — | WO | disclosed |
| US-20230038917-A1 | COMPOSITION COMPRISING CANNABINOIDS FOR RELIEF OF PAIN | TWEED INC (CA) | 2023-02-09 | — | — | US | disclosed |
| US-11491118-B2 | Composition comprising cannabinoids for relief of pain | TWEED INC. (CA) | 2022-11-08 | — | — | US | disclosed |
| WO-2022226639-A1 | WATER-SOLUBLE CANNABIS CANNABINOID SYSTEMS FOR INFUSING PRODUCTS WITH NANOEMULSIONS HAVING NANOSCALE SIZES | HEXO OPERATIONS INC. (CA) | 2022-11-03 | — | — | WO | disclosed |
| US-20220202710-A1 | WATER-SOLUBLE FORMULATIONS, METHODS OF MAKING AND USE | CANOPY GROWTH CORPORATION (CA) | 2022-06-30 | — | — | US | disclosed |
| US-20210361592-A1 | COMPOSITION COMPRISING CANNABINOIDS FOR RELIEF OF PAIN | JGB COLLATERAL LLC | 2021-11-25 | — | — | US | disclosed |
| US-20200289459-A1 | LIQUID DOSAGE FORMS, METHODS OF MAKING AND USE | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2020-09-17 | — | — | US | disclosed |
| WO-2020107114-A1 | WATER-SOLUBLE FORMULATIONS OF CANNABINOIDS OR CANNABIS-DERIVED COMPOUNDS, METHODS OF MAKING AND USE | CANOPY GROWTH CORPORATION (CA) | 2020-06-04 | — | — | WO | disclosed |
| WO-2020107119-A1 | COMPOSITIONS COMPRISING A CANNABINOID OR A CANNABIS-DERIVED COMPOUND, METHODS OF MAKING AND USE | CANOPY GROWTH CORPORATION (CA) | 2020-06-04 | — | — | WO | disclosed |
| US-20200170944-A1 | WATER-SOLUBLE FORMULATIONS, METHODS OF MAKING AND USE | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2020-06-04 | — | — | US | disclosed |
| US-20200170950-A1 | COMPOSITIONS COMPRISING A CANNABINOID OR A CANNABIS-DERIVED COMPOUND, METHODS OF MAKING AND USE | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2020-06-04 | — | — | US | disclosed |
| US-20200138737-A1 | COMPOSITION COMPRISING CANNABINOIDS FOR RELIEF OF PAIN | JGB COLLATERAL LLC | 2020-05-07 | — | — | US | disclosed |
| WO-2019200482-A1 | CANNABIS PLACEBO COMPOSITIONS, DELIVERY VEHICLES AND A METHOD FOR COLOUR MATCHING/NEUTRALIZATION OF CANNABIS PRODUCTS | CANOPY GROWTH CORPORATION (CA) | 2019-10-24 | — | — | WO | disclosed |
| US-20190321330-A1 | CANNABIS PLACEBO COMPOSITIONS, DELIVERY VEHICLES AND A METHOD FOR COLOUR MATCHING/NEUTRALIZATION OF CANNABIS PRODUCTS | CANOPY GROWTH CORPORATION (CA) | 2019-10-24 | — | — | US | disclosed |
| WO-2019175290-A1 | CANNABIS OR CANNABIS DERIVED COMPOSITIONS FOR PROMOTING CESSATION OF CHEMICAL DEPENDENCE | BECKLEY CANOPY THERAPEUTICS LIMITED (GB) | 2019-09-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12485129-B2 | Water soluble compositions comprising purified cannabinoids | CNR2, CNR1, PTGES | CYP3A4 2530/4885SLC7A5 2414/4885CPB2 1998/4885 |
| US-20200170944-A1 | WATER-SOLUBLE FORMULATIONS, METHODS OF MAKING AND USE | CNR1, CNR2, FAAH | CYP3A4 3318/4885SLC7A5 2425/4885CPB2 4399/4885 |
| US-20190321330-A1 | CANNABIS PLACEBO COMPOSITIONS, DELIVERY VEHICLES AND A METHOD FOR COLOUR MATCHING/NEUTRALIZATION OF CANNABIS PRODUCTS | CNR2, CNR1, OPRM1 | CYP3A4 45/4885SLC7A5 4540/4885CPB2 3543/4885 |
| US-20220202710-A1 | WATER-SOLUBLE FORMULATIONS, METHODS OF MAKING AND USE | CNR1, CNR2, FAAH | CYP3A4 3318/4885SLC7A5 2425/4885CPB2 4399/4885 |
| US-20200170950-A1 | COMPOSITIONS COMPRISING A CANNABINOID OR A CANNABIS-DERIVED COMPOUND, METHODS OF MAKING AND USE | CNR1, CNR2, CSGALNACT1 | CYP3A4 731/4885SLC7A5 4306/4885CPB2 2796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.